x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

44:41

Why biotechs are feeling the bite

Molecule to Market: Inside the outsourcing space ·

2023/04/21

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Allan Shaw, CFO, Special Advisor & Board Member of several biotech companies, including Portage Biotech. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Allan, covering: Allan’s updated view on what is happening in the market since he was on the show last summer and his own change in investment focus Why a downturn, negative enterprise

en

46:02

The Amalgamator of Biz and Bio

Molecule to Market: Inside the outsourcing space ·

2023/04/14

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Oren Beske, Amalgamator of Business and Biology at ATUM. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Oren, covering: How he ended up at Atum with one of the most peculiar job titles in the industry... The balance (and conflict) of combining a world-class science offering with the economic need of needing to monetise a business The

en

45:06

The 30-year biotech and CDMO entrepreneur

Molecule to Market: Inside the outsourcing space ·

2023/04/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Derek Hennecke, biotech and CDMO Entrepreneur and Board Member. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Derek, covering: The behind-the-scenes story of acquiring, growing and selling Xcelience to Capsugel Why Derek loves a carve-out with a clear differentiating capability and bags of growth potential How he thinks about investments

en

53:31

The ATMP and CDMO deal maker

Molecule to Market: Inside the outsourcing space ·

2023/03/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Anderson, General Partner at Ampersand Capital Partners. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering: What a world-class healthcare PE company looks for, and is repelled by, in a pharma services acquisition target Behind the scenes of some of the biggest M&A deals in the outsourcing space in recent years -

en

43:23

From AZ to CRO Founder

Molecule to Market: Inside the outsourcing space ·

2023/03/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Paul Dickinson, Founder and CSO at Seda Pharmaceutical Development Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Paul, covering: The success factors and a behind-the-scenes look at one of AstraZeneca’s fastest development programs – from the start of clinical trials to approval in just over two and a half years to meet unmet

en

50:53

The iterative nature of emerging therapeutics

Molecule to Market: Inside the outsourcing space ·

2023/03/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jennifer Chadwick, CSO of ProtaGene. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jennifer, covering: Lessons and learnings moving from the world of academia into commercial industry The shift from lowest-price tactical outsourcing to value-based, holistic, and strategic outsourcing at a much earlier stage Nuances in the sandbox of

en

46:26

Think Star Trek, Think Smart Labs

Molecule to Market: Inside the outsourcing space ·

2023/03/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Henal Shah, Life Sciences Lab Practice Head at Cognizant. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Henal, with a focus on: Decoding digital transformation and what it means for pharmaceutical companies across the life sciences supply chain Delivering fascinating insights into what a state-of-the-art smart factory and lab of the

en

35:03

Founding and selling three bio CDMOs - Part 2

Molecule to Market: Inside the outsourcing space ·

2023/03/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Bamforth, Entrepreneur, Mentor and Investor in life sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: How an unsolicited offer led to the unplanned sale of Arranta Bio to global CDMO Recipharm Mark’s ability to spot trends of where the sector is going, and sometimes going against conventional wisdom How Mark

en

49:24

Founding and selling three bio CDMOs - Part 1

Molecule to Market: Inside the outsourcing space ·

2023/02/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Bamforth, Entrepreneur, Mentor and Investor in life sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: Mark’s backstory from oil barrels to brewing, to a small biotech called... Genzyme A baptism of fire of having to raise money for a self-funded CDMO carve-out after 22 years in the corporate world How a merger

en

23:24

Network like a pro

Molecule to Market: Inside the outsourcing space ·

2023/02/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal, covering his top tips for networking ahead of this year’s events season after two decades of learning the do's and dont's, and making the mistakes for you. This episode covers; The importance of networking and how vital human interaction is to keep business going Being your own brand and understanding your network is your net worth Judging a book by its cover, and

en

29:53

Diversity in life sciences

Molecule to Market: Inside the outsourcing space ·

2023/02/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal for a special lookback episode on the topic of diversity in the life sciences space. This week’s episode features excerpts from conversations with; Barbara Morgan (Lubrizol at time of recording), now Global Vice President, Pharma and Biotechnology at Kerry discussing; gender diversity and the network of women supporting each other in their roles. Tia Lyles-Williams,

en

47:53

The CDMO CEO on the frontline of a Covid mission

Molecule to Market: Inside the outsourcing space ·

2023/02/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Ross, President and CEO at Grand River Aseptic Manufacturing (GRAM). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: How a passive investment in a small growing business led to running one of the most reputable CDMOs in the US Insights of how to pivot from lumpy clinical supply to sustainable commercial revenues

en

51:18

Industry insights you cannot afford to miss

Molecule to Market: Inside the outsourcing space ·

2023/01/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ian Tzeng, Managing Director at L.E.K. Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ian, covering: Insights, trends and advice for CROs, CDMOs and pharma services firms from one of the most prominent life science consultants. What he gained from his time studying at Harvard and the importance of genuine curiosity and a

en

47:43

The Puzzle-Solving Lifelong Science Geek

Molecule to Market: Inside the outsourcing space ·

2023/01/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Aldridge, Chief Strategy Officer at Form Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Claire, covering: How a family ritual of solving puzzles played a role in developing an entrepreneurial spirit of problem solving Learn about how and why Northern Texas is becoming a destination for biotech and life sciences Going viral for

en

44:48

The CDMO with a capital D

Molecule to Market: Inside the outsourcing space ·

2023/01/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Harry Christiaens, CEO at Ardena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Harry, covering: How a regulatory change led a small consultancy down the path of becoming one of Europe’s most respected mid-sized CDMOs The easy-theory of an M&A buy-and-build strategy, versus the challenging practical realities after acquiring and

en

58:01

100 episodes of Molecule to Market: looking back,...

Molecule to Market: Inside the outsourcing space ·

2023/01/06

In this special episode of Molecule to Market, we are marking our 100th episode! Join us as we look back, review our learnings and lay the land for episode 101… For those that have been here since the beginning, we are incredibly grateful for your constant support and feedback. To our new listeners, thank you for joining the journey, seeing us through to 30,000 downloads and beyond. To our guests - thank you for being a part of this experience with us and taking the time to share your story. The

en

22:52

Raman’s review of life science in 2022

Molecule to Market: Inside the outsourcing space ·

2022/12/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the last 12 months in the life science industry. He covers his 5 key trends from the year including: The biotech capital market slowdown and its impact on the outsourcing space Sustainability as the hot topic within the sector, from events to company practices Businesses operating in an increasingly digital way and what that means for

en

20:01

A blast from the life science past

Molecule to Market: Inside the outsourcing space ·

2022/12/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with a look back to some of our early guests from the Molecule to Market archive. Your host, Raman Sehgal, recaps his discussions on the pharmaceutical and biotechnology supply chain with: Stefano Console, founder and Senior Advisor at Oriento discussing: founding his business in Switzerland and the fractional management staffing structure that is helping Oriento succeed Claire

en

39:48

Tackling the 3 Big C’s: CDMO Career, Children & Cancer

Molecule to Market: Inside the outsourcing space ·

2022/12/16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sarah Stevens, SVP and Head of Early Development & Late Stage Commercial Operations at Quotient Sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sarah, covering: Carving an incredible transatlantic CDMO career in traditionally non-female roles - balancing work, kids and breast cancer. Words of wisdom for young women developing

en

45:06

Mystic Miller’s review of ’22 and predictions for ’23

Molecule to Market: Inside the outsourcing space ·

2022/12/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with independent life sciences consultant Jim Miller. Your host, Raman Sehgal sits down with Jim covering: The three biggest macro factors impacting the CDMO space right now How CDMOs and CROs are starting to feel the pain of emerging biotech’s funding woes What we can learn from the 08-09 financial crash that can help CDMOs/CROs during rockier financial times The cooling of M&A and

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter